Total Payments
$34,792
2024 Payments
$31,521
Companies
23
Transactions
238
Medicare Patients
35,389
Medicare Billing
$5.0M
Payment Breakdown by Category
Other$29,284 (84.2%)
Food & Beverage$5,494 (15.8%)
Education$13.89 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $29,284 | 11 | 84.2% |
| Food and Beverage | $5,494 | 226 | 15.8% |
| Education | $13.89 | 1 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Amgen Inc. | $30,821 | 53 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $1,083 | 71 | $0 (2024) |
| Esperion Therapeutics, Inc. | $697.18 | 24 | $0 (2024) |
| Abbott Laboratories | $301.28 | 6 | $0 (2024) |
| Bayer HealthCare Pharmaceuticals Inc. | $248.25 | 3 | $0 (2018) |
| Daiichi Sankyo Inc. | $234.40 | 13 | $0 (2024) |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | $222.06 | 10 | $0 (2017) |
| Medtronic Vascular, Inc. | $159.11 | 2 | $0 (2017) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $151.11 | 8 | $0 (2024) |
| Novo Nordisk Inc | $150.07 | 7 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $31,521 | 95 | Amgen Inc. ($30,466) |
| 2023 | $741.49 | 37 | Novartis Pharmaceuticals Corporation ($300.04) |
| 2022 | $588.32 | 29 | Novartis Pharmaceuticals Corporation ($229.11) |
| 2021 | $548.13 | 29 | Esperion Therapeutics, Inc. ($359.98) |
| 2020 | $119.93 | 1 | Esperion Therapeutics, Inc. ($119.93) |
| 2019 | $157.12 | 11 | Amgen Inc. ($58.57) |
| 2018 | $255.52 | 11 | Bayer HealthCare Pharmaceuticals Inc. ($121.61) |
| 2017 | $861.33 | 25 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) ($222.06) |
All Payment Transactions
238 individual payment records from CMS Open Payments — Page 1 of 10
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | Amgen Inc. | Repatha (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,800.00 | General |
| Category: Cardiology | ||||||
| 12/12/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $120.00 | General |
| Category: Cardiology | ||||||
| 12/12/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $17.17 | General |
| Category: DIABETES | ||||||
| 12/09/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $9.05 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/25/2024 | Amgen Inc. | Repatha (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,800.00 | General |
| Category: Cardiology | ||||||
| 11/21/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Cardiology | ||||||
| 11/20/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $2.09 | General |
| Category: Cardiology | ||||||
| 11/08/2024 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $17.91 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 10/26/2024 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $19.48 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 10/24/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $9.71 | General |
| Category: Cardiology | ||||||
| 10/24/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $9.71 | General |
| Category: Cardiology | ||||||
| 10/16/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $1.76 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/14/2024 | Daiichi Sankyo Inc. | INJECTAFER (Drug) | Food and Beverage | In-kind items and services | $19.47 | General |
| Category: Iron Deficiency Anemia | ||||||
| 10/10/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $25.67 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/10/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $22.70 | General |
| Category: DIABETES | ||||||
| 10/10/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $0.76 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/07/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $13.21 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/27/2024 | Amgen Inc. | Repatha (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,800.00 | General |
| Category: Cardiology | ||||||
| 09/26/2024 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $24.37 | General |
| Category: Diabetes | ||||||
| 09/23/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $125.63 | General |
| Category: Cardiology | ||||||
| 09/19/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $8.52 | General |
| Category: Cardiology | ||||||
| 09/19/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $8.19 | General |
| Category: Cardiology | ||||||
| 09/18/2024 | Amgen Inc. | Repatha (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,800.00 | General |
| Category: Cardiology | ||||||
| 09/18/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $19.61 | General |
| Category: DIABETES | ||||||
| 09/12/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Cardiology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 23 | 8,956 | 14,197 | $5.0M | $1.5M |
| 2022 | 25 | 8,414 | 13,394 | $4.5M | $1.2M |
| 2021 | 30 | 8,933 | 13,908 | $4.5M | $1.2M |
| 2020 | 31 | 9,086 | 14,191 | $4.6M | $1.1M |
Total Patients
35,389
Total Services
55,690
Medicare Billing
$5.0M
Procedure Codes
112
All Medicare Procedures & Services
112 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| A9502 | Technetium tc-99m tetrofosmin, diagnostic, per study dose | Office | 2023 | 488 | 977 | $406,432 | $309,626 | 76.2% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Office | 2023 | 513 | 515 | $805,975 | $219,034 | 27.2% |
| 93880 | Ultrasound of both sides of head and neck blood flow | Office | 2023 | 1,083 | 1,147 | $790,283 | $206,941 | 26.2% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 1,148 | 1,276 | $882,992 | $191,657 | 21.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 981 | 1,489 | $658,138 | $168,456 | 25.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 1,228 | 1,947 | $609,411 | $149,888 | 24.6% |
| J2785 | Injection, regadenoson, 0.1 mg | Office | 2023 | 412 | 1,652 | $267,624 | $69,286 | 25.9% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 1,629 | 3,634 | $188,968 | $47,025 | 24.9% |
| 93015 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | Office | 2023 | 478 | 480 | $118,080 | $27,765 | 23.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 194 | 194 | $112,326 | $25,182 | 22.4% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 64 | 68 | $40,787 | $10,567 | 25.9% |
| 93923 | Complete ultrasound study of arm and leg arteries | Office | 2023 | 47 | 47 | $21,808 | $5,335 | 24.5% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 72 | 102 | $17,646 | $4,812 | 27.3% |
| 99221 | Initial hospital care with straightforward or low level of medical decision making, per day, if using time, at least 40 minutes | Facility | 2023 | 55 | 55 | $16,005 | $4,294 | 26.8% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 26 | 26 | $11,622 | $3,122 | 26.9% |
| 99407 | Smoking and tobacco use intensive counseling, more than 10 minutes | Office | 2023 | 49 | 73 | $7,008 | $2,381 | 34.0% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2023 | 291 | 316 | $8,848 | $2,273 | 25.7% |
| 93017 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) | Office | 2023 | 34 | 34 | $4,454 | $726.30 | 16.3% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 13 | 13 | $2,574 | $650.04 | 25.3% |
| 93018 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | Office | 2023 | 48 | 48 | $2,208 | $601.44 | 27.2% |
| 93016 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | Office | 2023 | 34 | 34 | $2,346 | $508.41 | 21.7% |
| J0280 | Injection, aminophyllin, up to 250 mg | Office | 2023 | 47 | 48 | $1,008 | $396.93 | 39.4% |
| J1250 | Injection, dobutamine hydrochloride, per 250 mg | Office | 2023 | 22 | 22 | $396.00 | $144.81 | 36.6% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Office | 2022 | 452 | 455 | $748,451 | $203,086 | 27.1% |
| 93880 | Ultrasound of both sides of head and neck blood flow | Office | 2022 | 957 | 1,015 | $729,785 | $186,113 | 25.5% |
About Dr. David Dagate, M.D
Dr. David Dagate, M.D is a Specialist healthcare provider based in Smithtown, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/18/2005. The National Provider Identifier (NPI) number assigned to this provider is 1790784395.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. David Dagate, M.D has received a total of $34,792 in payments from pharmaceutical and medical device companies, with $31,521 received in 2024. These payments were reported across 238 transactions from 23 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($29,284).
As a Medicare-enrolled provider, Dagate has provided services to 35,389 Medicare beneficiaries, totaling 55,690 services with total Medicare billing of $5.0M. Data is available for 4 years (2020–2023), covering 112 distinct procedure/service records.
Ad
Practice Information
- Specialty Specialist
- Location Smithtown, NY
- Active Since 07/18/2005
- Last Updated 04/17/2008
- Taxonomy Code 174400000X
- Entity Type Individual
- NPI Number 1790784395
Products in Payments
- Repatha (Biological) $30,752
- LEQVIO (Drug) $604.89
- ENTRESTO (Drug) $477.62
- NEXLETOL (Drug) $455.94
- Adempas (Drug) $248.25
- NEXLIZET (Drug) $241.24
- LifeVest (Device) $222.06
- INJECTAFER (Drug) $220.63
- CardioMEMS HF System (Device) $180.08
- 3F (Device) $159.11
- JARDIANCE (Drug) $151.11
- ELIQUIS (Drug) $129.52
- FFRct (Device) $82.85
- XARELTO (Drug) $77.89
- Livalo (Drug) $73.87
- Corlanor (Drug) $68.99
- Ozempic (Drug) $67.39
- CARDIOMEMS (Device) $51.49
- BRILINTA (Drug) $49.36
- ICDs (Device) $47.72
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Specialist Doctors in Smithtown
Dr. Mohammad Bilal, M.d, M.D
Specialist — Payments: $28,836
Specialist $28,836
Armen Ovsepian, M.d, M.D
Specialist — Payments: $19,122
Specialist $19,122
Ezra Deutsch, M.d, M.D
Specialist — Payments: $18,346
Specialist $18,346
Dr. Sandra Iannotti, M.d, M.D
Specialist — Payments: $5,308
Specialist $5,308
Mrs. Kathleen Van Valkenburg, Md, MD
Specialist — Payments: $3,747
Specialist $3,747
Dr. Mark Sterling, M.d, M.D
Specialist — Payments: $2,075
Specialist $2,075